# High Tide Inc. (HITI)

> Source: Nexqual · https://nexqual.com/HITI · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, High Tide Inc. (HITI), nexqual.com/HITI" · informational, not investment advice.

**Price:** USD 2.56 (-0.78% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.58 · day 2.55–2.65 · 52w 2.02–3.5 · market cap $228M · NCM

## Key facts
- Analysts: Buy (mean 1.86 on a 1–5 scale) (7 analysts), mean target USD 4.67 (range 4–5).
- Total return with dividends: 1Y -25.6% vs S&P 500 +18.1%; 5Y -54.7% vs S&P 500 +85.1%.
- Next earnings: 2026-09-14, EPS estimate USD 0.03, revenue estimate $202M.

## Analysts
Consensus Buy (mean 1.86 on a 1–5 scale), 7 analysts; mean target USD 4.67 (low 4, high 5).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -25.6% | -54.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -25.7% | -14.6% |
| Volatility (annualized) | 43.0% | 65.2% |
| Max drawdown | -40.4% (Oct 2025→Jul 2026) | -85.9% (Nov 2021→Mar 2023) |

## Peers (Pharmaceutical Retailers)
HUM (Humana Inc.) USD 432.2 +2.81% · BDX (Becton, Dickinson and Company) USD 193.76 +3.41% · ARGX (argenx SE) USD 846.27 +5.44% · NTRA (Natera, Inc.) USD 404.79 +2.31% · CAH (Cardinal Health, Inc.) USD 253.71 +5.84% · TAK (Takeda Pharmaceutical Company L) USD 19.45 +5.02%

## More
Full page: https://nexqual.com/HITI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt